模型引导的药物研发在中药中的应用优势和进展
x

请在关注微信后,向客服人员索取文件

篇名: 模型引导的药物研发在中药中的应用优势和进展
TITLE: Advantage and progress of model-induced drug development in traditional Chinese medicine
摘要: 模型引导的药物研发(MIDD)是一种用于构建、验证和利用疾病模型、药物暴露反应模型和药学模型来促进药物开发的数学和统计方法。随着制药技术的发展,MIDD在中药领域应用广泛,具有较高的实用价值。本文总结了国内外相关文献,发现MIDD具有提高中药研发效率、快速明确中药的适用人群、预测药物的交互作用、优化给药剂量等优势,且在中药药效成分、组方定量设计、剂型和制剂工艺、中试放大、质量与安全性、监管决策与评价等研究方面均有应用。
ABSTRACT: Model-induced drug development (MIDD) is a mathematical and statistical method for constructing, validating and utilizing disease model, drug exposure-response model and pharmaceutical model to promote drug development. With the development of pharmaceutical technology, MIDD is widely used in the field of traditional Chinese medicine and has high practical value. This article summarizes the relevant literature at home and abroad, and finds that MIDD has the advantages of improving the research and development efficiency of traditional Chinese medicine, quickly identifying the applicable population of traditional Chinese medicine, predicting the interaction of drugs, and optimizing the dosage. MIDD has been applied in the studies of effective components of traditional Chinese medicine, quantitative design of prescription, dosage form and preparation process, pilot scale- up, quality and safety, regulatory decision-making and evaluation, etc.
期刊: 2023年第34卷第21期
作者: 黄慧辰;钟萍;张海燕
AUTHORS: HUANG Huichen,ZHONG Ping,ZHANG Haiyan
关键字: 模型引导的药物研发;中药;应用优势;应用进展
KEYWORDS: model-induced drug development; traditional Chinese medicine; application advantage; application advance
阅读数: 85 次
本月下载数: 9 次

* 注:未经本站明确许可,任何网站不得非法盗链资源下载连接及抄袭本站原创内容资源!在此感谢您的支持与合作!